| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |